HANKIL LEE Associate Professor

Pharmaceutical Sciences/Industrial Pharmaceutical Science/Division of Pharmacy

이한길 프로필 사진

				
  • Pharmaceutical Science Building B #411
  • 02-3277-4504
  • Research Interests
    • Health Technology Assessment, Economic Evaluation, Regulatory Science, Outcomes Research, Pharmacoepidemiology
Research Record
  • [학술지논문] A multicenter micro-costing analysis of flexible cystoscopic procedures in Korea Investigative and Clinical Urology, 2025, v.66 no.- , 87-96
    SCIE
  • [학술지논문] Assessing the Risk of Cognitive Impairment associated with Androgen Receptor Targeting Agent Use in Metastatic Prostate Cancer: A Systematic Review of Real-world Data Yakhak Hoeji, 2025, v.69 no.2 , 125-134
  • [학술지논문] COVID-19 infection in patients with end-stage kidney disease undergoing renal replacement therapies in Korea Kidney Research and Clinical Practice, 2025, v.44 no.3 , 522-534
    SCIE
  • [학술지논문] Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea NEPHROLOGY, 2025, v.30 no.6 , 1-1
    SCIE
  • [학술지논문] Incidence and risk of drug-induced interstitial lung cancer disease associated with anti-neoplastic drugs: a nested case–control study from Korean cancer patients EXPERT OPINION ON DRUG SAFETY, 2025, v.3 no.3 , 1-9
    SCIE
  • [학술지논문] Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records PLOS ONE, 2025, v.20 no.1 , 1-1
    SCIE
  • [학술지논문] Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort SCIENTIFIC REPORTS, 2025, v.15 no.- , 23490-23490
    SCIE
  • [학술지논문] Self-testing strategy to eliminate Hepatitis C as per WHO’s goal: Analysis of disease burden and cost-effectiveness Clinical and molecular hepatology, 2025, v.31 no.- , 166-178
    SCIE
  • [학술지논문] Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease CLINICAL THERAPEUTICS, 2024, v.46 no.9 , 670-676
    SCIE
  • [학술지논문] Determinants of immune checkpoint inhibitor use and factors linked to neurological adverse events in Korean lung cancer FUTURE ONCOLOGY, 2024, v.20 no.39 , 3245-3256
    SCIE
  • [학술지논문] Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, v.17 no.4 , 13801-13801
    SCIE
  • [학술지논문] Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, v.39 no.6 , 967-978
    SCIE
  • [학술지논문] Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, v.39 no.4 , 240-249
    SCIE
  • [학술지논문] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study CURRENT MEDICAL RESEARCH AND OPINION, 2024, v.40 no.12 , 2155-2162
    SCIE
Courses
Academic Background

YONSEI UNIVERSITY 약학박사(약학과)

Ewha Womans University 약학석사(생명약학부)

Ewha Womans University 약학사(제약학과)

Work Experience

아주대 2021-03-01 ~ 2025-02-28